SIGMAR1 and cancer: Thus, these findings emphasize an interesting area of research in which, the regulation of Sig-1R activity, may be an alternative to control the metastatic potential of certain types of cancers where the levels of Sig-1R are upregulated (i.e., colorectal or breast cancers) (Gueguinou et al., 2017).